Patents by Inventor Kiyoshi Kuriyama
Kiyoshi Kuriyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20070128287Abstract: The object of the present invention is to provide a dermal composition for external use which keeps skin healthy and demonstrates a sufficient effect in treating skin diseases. The present invention relates to a dermal composition for external use, which comprises sodium cromoglycate and a monoester of polyvalent alcohol and salicylic acid contained in a base.Type: ApplicationFiled: January 4, 2007Publication date: June 7, 2007Inventors: Koji Inagaki, Yoshiko Abe, Kiyoshi Kuriyama
-
Patent number: 7179476Abstract: The object of the present invention is to provide a dermal composition for external use which keeps skin healthy and demonstrates a sufficient effect in treating skin diseases. The present invention relates to a dermal composition for external use, which comprises sodium cromoglycate and a monoester of polyvalent alcohol and salicylic acid contained in a base.Type: GrantFiled: August 9, 2002Date of Patent: February 20, 2007Assignee: Sekisui Chemical Co., Ltd.Inventors: Koji Inagaki, Yoshiko Abe, Kiyoshi Kuriyama
-
Publication number: 20060275328Abstract: It is intended to provide a novel instrument for inducing a cytokine and a method of inducing a cytokine by which a cytokine can be effectively induced compared to the existing cytokine induction therapy. Namely, an instrument for inducing a cytokine which contains a hemolytic streptococcus and/or a hemolytic streptococcus-origin component and a water-insoluble carrier; and a method of inducing a cytokine by using this instrument for inducing a cytokine.Type: ApplicationFiled: April 26, 2004Publication date: December 7, 2006Applicant: SEKISUI CHEMICAL CO., LTD.Inventors: Shinichiro Kitahara, Kazuo Shinmura, Yoshiko Abe, Kiyoshi Kuriyama
-
Publication number: 20060105988Abstract: It is the object of the present invention to provide a composition which has an antipruritic effect on skin and further exhibits good appearance and feeling of usage. The present invention relates to an antipruritic composition for external use on skin, which contains a mucopolysaccharide or a derivative thereof in an amount of 0.5 to 20 weight %.Type: ApplicationFiled: March 25, 2004Publication date: May 18, 2006Inventors: Tatsuo Shimizu, Kiyoshi Kuriyama
-
Publication number: 20050013791Abstract: A cytokine-inducing material and a cytokine-inducing instrument to be used in cytokine-induction therapy and the like. More specifically speaking, a cytokine-inducing material characterized by containing a water-insoluble induction potentiator comprising a cytokine-inducer such as BCG, a polymer, etc.; and a cytokine-inducing instrument having this inducing material packed in a container. By bringing the inducing material into contact with, for example, blood or blood components, cytokine can be induced more effectively than conventional cases.Type: ApplicationFiled: October 31, 2002Publication date: January 20, 2005Inventors: Kazuo Shinmura, Kiyoshi Kuriyama
-
Publication number: 20040213749Abstract: The object of the present invention is to provide a dermal composition for external use which keeps skin healthy and demonstrates a sufficient effect in treating skin diseases.Type: ApplicationFiled: May 7, 2004Publication date: October 28, 2004Inventors: Koji Inagaki, Yoshiko Abe, Kiyoshi Kuriyama
-
Patent number: 6468734Abstract: An object is to obtain a container for measurement of cell functions which is simplified in operation, less risky and capable of measuring the cell functions very accurately. A container for measurement of cell functions, for use in the determination of a physiologically active substance produced by blood cells, is constituted such that an amount of material capable of inducing production of the physiologically active substance, when extracted by collecting water of a volume equal to a liquid volume to be subjected to measurement, is controlled at a level insufficient to induce production of the physiologically active substance from the blood cells.Type: GrantFiled: January 4, 2001Date of Patent: October 22, 2002Assignee: Sekisui Kagaku Kogyo Kabushiki KaishaInventors: Koji Kobayashi, Yuji Setoguchi, Kiyoshi Kuriyama
-
Patent number: 6458548Abstract: A container for measurement of cell functions, for use in the determination of a physiologically active substance produced by blood cells, is constituted such that an amount of material capable of inducing production of the physiologically active substance, when extracted by collecting water of a volume equal to a liquid volume to be subjected to measurement, is controlled at a level insufficient to induce production of the physiologically active substance from the blood cells. A container for measurement of cell functions in which a material capable of inducing production of a physiologically active substance in blood when contacted with the blood is accommodated in such a condition as being contactable with blood, and in which an amount of the material capable of inducing production of the physiologically active substance in the container before use is limited to a level insufficient to influence a measured value of the physiologically active substance.Type: GrantFiled: April 1, 1998Date of Patent: October 1, 2002Assignee: Sekisui Kagaku Kogyo Kabushiki KaishaInventors: Koji Kobayashi, Yuji Setoguchi, Kiyoshi Kuriyama
-
Patent number: 6306898Abstract: The first invention provides an external preparation for treating dermatoses comprising vitamin E and squalane, which has an efficacy at least equivalent to that of external preparations containing adrenocortical hormones as the active ingredient. The second invention provides an external preparation for treating dermatoses comprising an adrenocortical hormone, vitamin E and squalane, which is reduced in adrenocortical hormone content as compared with conventional preparations, is also reduced in side effects, and has high clinical efficacy. The third invention provides an external preparation for treating dermatoses comprising a nonsteroidal antiinflammatory agent, vitamin E and squalane and/or squalene, which is reduced in side effects and is highly efficacious. The fourth invention provides an external preparation for treating dermatoses comprising an antihistaminic agent, vitamin E and squalane and/or squalene, which is reduced in side effects and is highly efficacious like the above preparation.Type: GrantFiled: December 9, 1999Date of Patent: October 23, 2001Assignee: Sekisui Kaisha Kogyo Kabushiki KaishaInventors: Tatsuo Shimizu, Tomoko Horiguchi, Kiyoshi Kuriyama, Mitsuo Watabe
-
Publication number: 20010014443Abstract: An object is to obtain a container for measurement of cell functions which is simplified in operation, less risky and capable of measuring the cell functions very accurately.Type: ApplicationFiled: January 4, 2001Publication date: August 16, 2001Applicant: SEKISUI KAGAKU KOGYO KABUSHIKI KAISHAInventors: Koji Kobayashi, Yuji Setoguchi, Kiyoshi Kuriyama
-
Publication number: 20010006791Abstract: An object is to obtain a container for measurement of cell functions which is simplified in operation, less risky and capable of measuring the cell functions very accurately.Type: ApplicationFiled: April 1, 1998Publication date: July 5, 2001Inventors: KOJI KOBAYASHI, YUJI SETOGUCHI, KIYOSHI KURIYAMA
-
Patent number: 6248779Abstract: The first invention provides an external preparation for treating dermatoses comprising vitamin E and squalane, which has an efficacy at least equivalent to that of external preparations containing adrenocortical hormones as the active ingredient. The second invention provides an external preparation for treating dermatoses comprising an adrenocortical hormone, vitamin E and squalane, which is reduced in adrenocortical hormone content as compared with conventional preparations, is also reduced in side effects, and has high clinical efficacy. The third invention provides an external preparation for treating dermatoses comprising a nonsteroidal antiinflammatory agent, vitamin E and squalane and/or squalene, which is reduced in side effects and is highly efficacious. The fourth invention provides an external preparation for treating dermatoses comprising an antihistaminic agent, vitamin E and squalane and/or squalene, which is reduced in side effects and is highly efficacious like the above preparation.Type: GrantFiled: April 1, 1997Date of Patent: June 19, 2001Assignee: Sekisui Kagaku Kogyo Kabushiki KaishaInventors: Tatsuo Shimizu, Tomoko Horiguchi, Kiyoshi Kuriyama, Mitsuo Watabe
-
Patent number: 5858971Abstract: The present invention relates to a peptide represented by formula ?I!. The peptide of the present invention exhibits allergic and anallergic inflammation inhibitory, antibacterial, antitumor and wound-healing effects, and it is useful as an inflammation inhibitor, immunosuppressive agent, antibacterial agent, antitumor agent, wound-healing agent, antiulcer agent, and so forth. Accordingly, the present invention also provides therapeutic agents having the above-mentioned pharmacological effects.Type: GrantFiled: April 22, 1997Date of Patent: January 12, 1999Assignee: Sekisui Chemical Co., Ltd.Inventors: Akihiko Fujiwara, Kiyoshi Kuriyama, Yoshiko Abe, Koji Inagaki
-
Patent number: 5728577Abstract: A bioreactor includes a treatment tank for receiving liquid to be treated, at least one carrier member having a carrier body formed of porous materials and immobilized with nonagglutinative microorganisms for treating the liquid, and a drive unit for moving the at least one carrier member in the treatment tank.Type: GrantFiled: August 19, 1996Date of Patent: March 17, 1998Inventor: Kiyoshi Kuriyama
-
Patent number: 4913820Abstract: A process for treating organic sewage comprises the steps of mixing sewage containing organic pollutants with activated sludge under aerobic conditions, bringing the mixture of the sewage and activated sludge into contact with polyvinyl pyridine, thereby producing floc, and separating the floc from the liquid based on the difference in specific gravity.Type: GrantFiled: July 18, 1989Date of Patent: April 3, 1990Assignee: Kyoto Suiken Co., Ltd.Inventors: Nariyoshi Kawabata, Kiyoshi Kuriyama
-
Patent number: 4731375Abstract: A chromene derivative having the general formula (I): ##STR1## wherein n is 1 to 5 and --O--CH.sub.2).sub.n CO.sub.2 H group is attached to 5-position, 6-position, 7-position or 8-position, or salts thereof, a process for preparing the same and antiallergic agents containing the same.The compounds of the present invention inhibit the immunological release of chemical mediators such as SRS-A and histamine from mast cell and have an excellent effect in preventing and treating the various allergic diseases such as allergic asthma, allergic dermatitis, allergic nasitis, hives, allergic enteritis and allergic conjunctivitis, especially allergic asthma.Type: GrantFiled: December 9, 1985Date of Patent: March 15, 1988Assignee: Kaken Pharmaceutical Co., Ltd.Inventors: Jun Nakano, Toshikazu Awaji, Kiyoshi Kuriyama, Yoshiyuki Hiyama, Toshiaki Okuda
-
Patent number: 4363812Abstract: Coumarin derivatives of the general formula: ##STR1## wherein R is hydrogen atom, an alkyl group or an alkenyl group, R.sup.1 is hydrogen atom, an alkyl group, an alkenyl group or an alkoxy group, and the OR and R.sup.1 groups each are substituted at any of the 5, 6, 7 and 8 positions of the coumarin ring, and the salt thereof. The compounds are useful as antiallergic agent for preventing and treating allergic diseases.Type: GrantFiled: November 15, 1979Date of Patent: December 14, 1982Assignee: Kakenyaku Kako Co., Ltd.Inventors: Kiyoshi Kuriyama, Jun Nakano, Kiyonosin Itikawa, Kiyoshi Ito, Yuji Suzuki, Katsuro Ishizuki
-
Patent number: 4165281Abstract: A method and a unit for wastewater treatment with microorganisms, in which at least one non-woven fibrous mat having a three-dimensional network structure is disposed as a supporting media in an aeration tank, microorganisms are retained on the surface of and in the interstices of the non-woven fibrous mat, and organic polluting matter in the wastewater is oxidatively decomposed by the microorganisms in the presence of oxygen.Type: GrantFiled: September 26, 1977Date of Patent: August 21, 1979Assignee: Niigata Engineering Co., Ltd.Inventors: Kiyoshi Kuriyama, Munetaka Sato, Tsuneo Matsuzaki, Masanori Honma, Seiji Shida